Steven R Rousey, MD | |
6545 France Ave S, Ste 210, Edina, MN 55435-2281 | |
(952) 928-2900 | |
(952) 928-2944 |
Full Name | Steven R Rousey |
---|---|
Gender | Male |
Speciality | Hematology/oncology |
Experience | 39 Years |
Location | 6545 France Ave S, Edina, Minnesota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427027119 | NPI | - | NPPES |
23260 | Other | MN | AMERICA'S PPO |
111230 | Other | MN | UCARE MN |
0104007 | Other | MN | PREFERRED ONE |
115265300 | Medicaid | MN | |
31732700 | Medicaid | WI | |
3600789 | Other | MN | MEDICA |
HP14282 | Other | MN | HEALTHPARTNERS |
8T410RO | Other | MN | BLUE CROSS BLUE SHIELD MN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 34668 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Glencoe Regional Health Services | Glencoe, MN | Hospital |
Ridgeview Sibley Medical Center | Arlington, MN | Hospital |
Ridgeview Medical Center | Waconia, MN | Hospital |
Fairview Southdale Hospital | Edina, MN | Hospital |
Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Minnesota Oncology Hematology, Pa | 6709799752 | 104 |
News Archive
By adjusting the levels of a key signaling protein, researchers improved motor function and brain abnormalities in experimental animals with a form of Huntington's disease, a severe neurodegenerative disorder.
Short sleep duration is associated with an increased risk for suicidal ideation, a cross-sectional study of Korean adults shows.
Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3, head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic acid) in the treatment of bone metastases in 2,046 patients with advanced breast cancer that met its primary and secondary endpoints and demonstrated superior efficacy compared to Zometa.
The spread of the H1N1 virus and the growing concerns about treatments have illustrated the need for reliable sources of health care information. URAC, the nation's leading health care accreditation and education organization, offers a Health Call Center Accreditation which provides a framework for call centers around the country.
› Verified 8 days ago
Entity Name | Minnesota Oncology Hematology, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528035995 PECOS PAC ID: 6709799752 Enrollment ID: O20031106000626 |
News Archive
By adjusting the levels of a key signaling protein, researchers improved motor function and brain abnormalities in experimental animals with a form of Huntington's disease, a severe neurodegenerative disorder.
Short sleep duration is associated with an increased risk for suicidal ideation, a cross-sectional study of Korean adults shows.
Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3, head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic acid) in the treatment of bone metastases in 2,046 patients with advanced breast cancer that met its primary and secondary endpoints and demonstrated superior efficacy compared to Zometa.
The spread of the H1N1 virus and the growing concerns about treatments have illustrated the need for reliable sources of health care information. URAC, the nation's leading health care accreditation and education organization, offers a Health Call Center Accreditation which provides a framework for call centers around the country.
› Verified 8 days ago
Entity Name | Glencoe Regional Health Services |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1508885633 PECOS PAC ID: 1759292980 Enrollment ID: O20060504000699 |
News Archive
By adjusting the levels of a key signaling protein, researchers improved motor function and brain abnormalities in experimental animals with a form of Huntington's disease, a severe neurodegenerative disorder.
Short sleep duration is associated with an increased risk for suicidal ideation, a cross-sectional study of Korean adults shows.
Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3, head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic acid) in the treatment of bone metastases in 2,046 patients with advanced breast cancer that met its primary and secondary endpoints and demonstrated superior efficacy compared to Zometa.
The spread of the H1N1 virus and the growing concerns about treatments have illustrated the need for reliable sources of health care information. URAC, the nation's leading health care accreditation and education organization, offers a Health Call Center Accreditation which provides a framework for call centers around the country.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Steven R Rousey, MD 6545 France Ave S, Ste 210, Edina, MN 55435-2281 Ph: (952) 928-2900 | Steven R Rousey, MD 6545 France Ave S, Ste 210, Edina, MN 55435-2281 Ph: (952) 928-2900 |
News Archive
By adjusting the levels of a key signaling protein, researchers improved motor function and brain abnormalities in experimental animals with a form of Huntington's disease, a severe neurodegenerative disorder.
Short sleep duration is associated with an increased risk for suicidal ideation, a cross-sectional study of Korean adults shows.
Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3, head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic acid) in the treatment of bone metastases in 2,046 patients with advanced breast cancer that met its primary and secondary endpoints and demonstrated superior efficacy compared to Zometa.
The spread of the H1N1 virus and the growing concerns about treatments have illustrated the need for reliable sources of health care information. URAC, the nation's leading health care accreditation and education organization, offers a Health Call Center Accreditation which provides a framework for call centers around the country.
› Verified 8 days ago
Jonathan Avery Reynolds, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 6401 France Ave S, Edina, MN 55435 Phone: 952-924-5000 | |
Christopher Stefonowicz, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7450 France Ave S Ste 100, Edina, MN 55435 Phone: 952-832-8100 | |
Dr. Mohammad H Arbabi, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 6500 France Ave S, Edina, MN 55435 Phone: 952-924-8117 Fax: 844-422-7933 | |
Anne Marie Rosenberg, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7500 France Ave S, Edina, MN 55435 Phone: 952-835-1311 | |
David Lewis Bowlin, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 6363 France Ave S, Suite 400, Edina, MN 55435 Phone: 952-920-2070 Fax: 952-920-7444 | |
Jody Kay Hargrove, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7600 France Ave S Ste 5100, Edina, MN 55435 Phone: 952-893-1959 Fax: 952-893-1954 | |
Jeffrey Lee Wilson, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7600 France Ave S Ste 5100, Edina, MN 55435 Phone: 952-893-1959 Fax: 952-893-1954 |